Formaderm by He Kang Biotech Debuts at Beijing Beauty Expo with Eastern Aesthetic Focus

BeijingFebruary 27, 2023PR Newswire -- From February 22nd to 24th, the "27th Beijing International Beauty Expo," co-hosted by Guangzhou China International Beauty Expo and China International Slimming & Beauty Exhibition, was held at the Beijing National Convention Center. Maxigen Biotech Inc. (referred to as "Maxigen Biotech") made its debut with its medical aesthetics brand Fumedeng, presenting a meticulously designed booth that uniquely embodies Oriental aesthetics, fully showcasing Oriental beauty and cultural confidence.

Debut at Beijing Beauty Expo, Conveying Brand Philosophy with Oriental Aesthetics

As a grand event for the beauty and health industry, since its official entry into Beijing in 2017, the Beijing International Beauty Expo has been promoting the steady development of China's beauty industry. With联动 exhibitions in Beijing, Shanghai, and Guangzhou, it continues to play a significant role in the industry and has become a benchmark for China's beauty, hairdressing, and cosmetics sectors.

At this exhibition, more than 500 companies and over 1,500 brands gathered, covering professional lines, daily chemical lines, acne skin care, aromatic health, three-beauty industries, and other beauty industry supporting sectors. As a brand specializing in the research, development, and production of collagen and hyaluronic acid, applying core technology centered on biomacromolecular materials to biomedicine and medical aesthetics skincare products, Maxigen Biotech Inc. incorporated the concept of linear cross-linking of hyaluronic acid into its booth design. This created natural lines and aesthetics, combined with a color scheme of platinum and ivory white, not only highlighting the brand's high-end design style but also conveying the brand philosophy of "Craftsmanship Creates Elegance."

On the first day of the exhibition, Maxigen Biotech Inc. General Manager Chen Jingting, TaiMed Biologics Administrative Chief and Maxigen Biotech Shanghai Company General Manager Ni Jiali, and Maxigen Biotech Shanghai Company General Manager and China Operations Director Jiang Yan were present at the scene. Chen Jingting accepted an exclusive interview with CCTV's Science and Education Channel at the booth, discussing Maxigen Biotech’s experience and development in the R&D and production of hyaluronic acid and collagen.

"Since its establishment in 1998 and the commencement of collagen R&D work the following year, Maxigen Biotech has been deeply engaged in the research, development, and production of collagen and hyaluronic acid. It has now gradually developed core technologies centered on biomacromolecular materials, applied in the two major sectors of biomedical materials and medical aesthetics skincare products," said Chen Jingting. In the future, Maxigen Biotech will continue to develop and produce more collagen and hyaluronic acid products that integrate biopharmaceutical technology under the principles of 'quality safety, innovative R&D, customer satisfaction, and care for life' to meet consumer demands.

Integrating Biomedical Technology, the Star Brand Fumedeng Has a Prestigious Reputation in the Industry

During the exhibition, Maxigen Biotech's Fumei Deng Rejuvenating Collagen Peptide Drink, Fumei Deng series injectable sodium hyaluronate gel, and other productsGrandOn display, detailed product explanations at the scene attracted the attention and inquiries of many buyers and visitors.

As a star brand under Maxigen Biotech, Fumedo has gained a prestigious reputation in the industry and widespread recognition since entering the Chinese market in 2016 due to its high quality. After years of market refinement, the Fumedo series has optimized product features, further stabilizing injection force to deliver safer and more natural results to consumers while presenting itself with a refreshed product image in the Chinese market. Among its offerings, the oral beauty drink, Fumedo Radiance Collagen Peptide Beverage, hydrates with high-purity medium molecular weight hyaluronic acid, complementing the company’s cosmetics line to create ceramide-based moisture retention, promoting naturally hydrated skin, and comprehensively addressing facial aging to maintain a youthful appearance. Additionally, using its unique ECHA™ Equilibrium Crosslinking Technology, tangled hyaluronic acid molecular chains are untangled, dispersing minimal doses of micron-sized crosslinkers evenly around the hyaluronic acid to produce Fumedo Hyaluronic Acid Filler with uniform crosslinking, excellent viscoelasticity, and optimal extrusion force.

For a long time, Maxigen Biotech has adhered to the future ecological aesthetics of "scientific beauty and humanistic beauty," and collaborated with the R&D team of Great River Biomedical. After years of cross-disciplinary research, they eventually utilized medical-grade collagen development technology to create...The First in the IndustryCollagen Tripeptide. Mass spectrometry sequencing analysis has revealed that collagen tripeptide contains nine functional peptides, which, in addition to forming the structure of collagen, can also act as key initiators for specific repair functions. Today, Maxigen Biotech Inc.'s collagen and hyaluronic acid products integrate biomedical technology, offering greater flexibility to meet Eastern aesthetic standards. These products have been tested and certified by the U.S. FDA to ensure their quality.

Continuously Strengthening R&D in the Collagen Field to Accelerate the Maturation of China's Medical Aesthetics Industry

At this exhibition, Maxigen Biotech reached cooperation intentions with multiple local distributors, specialized hospitals, and institutions, further expanding its market presence in mainland China. Currently, the company’s main products for medical aesthetics and anti-aging are the FUMEDEN Zhiya, Zhiying, Zhiheng series, and the FUMEDEN Rejuvenating Collagen Tripeptide products. In addition, the company actively participates in international academic events such as the Oriental Medical Aesthetics Plastic Surgery Conference and the Merz Forum, continuously making efforts in the field of collagen research.

All along, Maxigen Biotech has highly recognized "Oriental Aesthetics" and firmly believed that under the guidance of the concept of "Scientific Beauty and Humanistic Beauty," China's medical aesthetics industry will accelerate towards maturity and standardization. In this process, high-quality brands like Fumeideng will have greater room for development, fully leveraging the advantages of Oriental Aesthetics to help Chinese consumers achieve natural, harmonious, and healthy Oriental soft beauty.